KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) EPS (Weighted Average and Diluted) (2020 - 2025)

Organon (OGN) has 6 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.78 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 290.24% year-over-year to -$0.78; the TTM value through Dec 2025 reached $0.72, down 78.38%, while the annual FY2025 figure was $0.72, 78.38% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.78 in Q4 2025 per OGN's latest filing, down from $0.61 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $2.13 in Q4 2023 and bottomed at -$0.78 in Q4 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.85, with a median of $0.77 recorded in 2021.
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 504.35% in 2024, then tumbled 290.24% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.76 in 2021, then tumbled by 44.74% to $0.42 in 2022, then surged by 407.14% to $2.13 in 2023, then plummeted by 80.75% to $0.41 in 2024, then crashed by 290.24% to -$0.78 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.78 in Q4 2025, $0.61 in Q3 2025, and $0.56 in Q2 2025.